Showing results (21-30 of 141) with videos related to
Sort By:
Pageof 15
International Journal of Radiation Oncology, Biology, Physics|June 24, 2009
Rad51 protein expression and survival in patients with glioblastoma multiformeJames W Welsh, Ron K Ellsworth, Rachit Kumar, et al.Cancer Journal (Sudbury, Mass.)|July 22, 2016
Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid TumorsEric D Brooks, Jonathan E Schoenhals, Chad Tang, et al.International Journal of Radiation Oncology, Biology, Physics|August 16, 2022
Local Therapy for Oligoprogressive Disease: A Systematic Review of Prospective TrialsHans Kim, Bhanu P Venkatesulu, Matthew T McMillan, et al.Research Square|February 24, 2023
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant modelHampartsoum B Barsoumian, Kewen He, Ethan Hsu, et al.Gynecologic Oncology|April 2, 2021
Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanomaDuygu Sezen, Roshal R Patel, Christine Tang, et al.Research Square|April 8, 2024
Hybridizing mechanistic mathematical modeling with deep learning methods to predict individual cancer patient survival after immune checkpoint inhibitor therapyJoseph D Butner, Prashant Dogra, Caroline Chung, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 11, 2019
Racial and Insurance-related Disparities in Delivery of Immunotherapy-type Compounds in the United StatesVivek Verma, Waqar Haque, Taylor R Cushman, et al.Journal of Thoracic Disease|March 30, 2018
Combining radiation plus immunotherapy to improve systemic immune responseTaylor R Cushman, Daniel Gomez, Rachit Kumar, et al.Cancer|February 21, 2013
Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapyVikas Bhardwaj, Tina Cascone, Maria Angelica Cortez, et al.NPJ Systems Biology and Applications|August 14, 2024
Hybridizing mechanistic modeling and deep learning for personalized survival prediction after immune checkpoint inhibitor immunotherapyJoseph D Butner, Prashant Dogra, Caroline Chung, et al.Pageof 15